A.R.T. Advisors’s Endocyte, Inc. Common Stock ECYT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-27,156
| Closed | -$38K | – | 1846 |
|
|
2017
Q3 | $38K | Sell |
27,156
-127,975
| -82% | -$179K | ﹤0.01% | 1270 |
|
|
2017
Q2 | $232K | Buy |
155,131
+115,011
| +287% | +$172K | 0.01% | 1106 |
|
|
2017
Q1 | $103K | Buy |
40,120
+15,020
| +60% | +$38.6K | ﹤0.01% | 1266 |
|
|
2016
Q4 | $64K | Buy |
+25,100
| New | +$64K | ﹤0.01% | 1197 |
|
|
2016
Q3 | – | Sell |
-30,273
| Closed | -$97K | – | 1439 |
|
|
2016
Q2 | $97K | Sell |
30,273
-63,700
| -68% | -$204K | ﹤0.01% | 1209 |
|
|
2016
Q1 | $291K | Buy |
93,973
+10,900
| +13% | +$33.8K | 0.01% | 1057 |
|
|
2015
Q4 | $333K | Buy |
83,073
+46,502
| +127% | +$186K | 0.02% | 1021 |
|
|
2015
Q3 | $167K | Buy |
36,571
+8,913
| +32% | +$40.7K | 0.01% | 1194 |
|
|
2015
Q2 | $143K | Sell |
27,658
-3,700
| -12% | -$19.1K | ﹤0.01% | 1325 |
|
|
2015
Q1 | $196K | Buy |
+31,358
| New | +$196K | 0.01% | 1237 |
|
|
2014
Q4 | – | Sell |
-311,217
| Closed | -$1.89M | – | 1788 |
|
|
2014
Q3 | $1.89M | Buy |
311,217
+5,242
| +2% | +$31.9K | 0.09% | 312 |
|
|
2014
Q2 | $2.02M | Buy |
305,975
+284,683
| +1,337% | +$1.88M | 0.11% | 281 |
|
|
2014
Q1 | $506K | Sell |
21,292
-16,472
| -44% | -$391K | 0.03% | 737 |
|
|
2013
Q4 | $403K | Sell |
37,764
-7,457
| -16% | -$79.6K | 0.02% | 862 |
|
|
2013
Q3 | $602K | Buy |
45,221
+8,751
| +24% | +$116K | 0.03% | 698 |
|
|
2013
Q2 | $478K | Buy |
+36,470
| New | +$478K | 0.02% | 892 |
|